Filters
Also try searching for:
CRI*
on 03 Apr 2023
CANADIAN INVESTMENT REGULATORY ORGANIZATION ORGANISME CANADIEN DE RÉGLEMENTATION DES INVESTISSEMENTS
2249631 · 03 Apr 2023
041
Class 041
Education and Entertainment Services
Setting, monitoring compliance with, providing educational services and enforcing rules regarding the proficiency, business and financial conduct of investment dealer firms, mutual fund dealer firms and their registered employees; and setting, monitoring compliance with, providing educational services and enforcing trading rules regarding trading activity on Canadian debt and equity marketplaces
Setting, monitoring compliance with, providing educational services an...
on 08 Dec 2023
CSL BEHRING L.L.C.
2183927 · 05 Apr 2022
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for the treatment of blood conditions; pharmaceutical preparations for transplant conditions; pharmaceutical preparations for renal transplant conditions; pharmaceutical preparations for kidney diseases, illnesses and conditions; pharmaceutical preparations for treatment of antibody mediated rejection in adult renal transplant recipients.
Pharmaceutical preparations for the treatment of blood conditions; pha...
on 27 Sep 2023
GLAXO GROUP LIMITED
2167105 · 11 Nov 2021
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus, respiratory syncytial virus, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders and their symptoms; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; pharmaceutical preparations for the treatment of atherosclerosis; pharmaceutical preparations for the treatment of viral conditions namely human immunodeficiency virus (HIV), HPV, RSV, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascular, cardiopulmonary, cardio-renal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain, bone pain and fatigue; pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, sepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure infections namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases; pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely hypogonadism, testosterone/androgen disorders and estrogen disorders; pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders and acid-related disorders; pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and female sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder and orgasm disorder; pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrheal and infertility; pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, Leiomyoma, endourology/stone, pre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of prostatitis, nephritis, cystitis, vaginitis, renal disease; pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders namely polycystic ovary syndrome; pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia (male pattern baldness); pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; pharmaceutical preparations for the treatment of damaged skin and tissue namely bee stings, sunburn, rashes, sores, corns, calluses and acne; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; allergy medications; vaccines namely prophylactic and therapeutic vaccines for humans; pharmaceutical preparations for the treatment of neurological diseases and disorders namely Parkinsons Disease, Alzheimers Disease, Huntingtons Disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory-related pain, fibromyalgia, stroke, multiple sclerosis, insomnia; pharmaceutical preparations for the treatment of central nervous system diseases and disorders namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders namely schizophrenia and psychoses; pharmaceutical preparations for the treatment of muscular dystrophy.
Pharmaceutical preparations for use as anti-infectives; pharmaceutical...
on 13 Oct 2020
NORTH CAROLINA STATE UNIVERSITY
987285 · 05 Nov 2018
031
Class 031
Natural Agricultural Products
Agricultural, horticultural and forestry
Agricultural, horticultural and forestry
on 20 Dec 2017
NOVO NORDISK A/S
1705400 · 02 Dec 2014
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for the treatment of diabetes.
Pharmaceutical preparations for the treatment of diabetes.
on 09 Oct 2019
GLAXO GROUP LIMITED
1676477 · 09 May 2014
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for use as anti-infectives; Pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), HPV, RSV, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; Pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders and their symptoms; Pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; Pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of atherosclerosis; Pharmaceutical preparations for the treatment of viral conditions namely human immunodeficiency virus (HIV), HPV, RSV, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; Pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; Pharmaceutical preparations for the treatment and prevention of cardiovascular, cardiopulmonary, cardio-renal and renal diseases and disorders; Pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; Pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; Pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain, bone pain and fatigue; Pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, sepsis and infections in and of the blood; Pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure infections namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases; Pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely hypogonadism, testosterone/androgen disorders and estrogen disorders; Pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders and acid-related disorders; Pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and female sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder and orgasm disorder; Pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; Pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrheal and infertility; Pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; Pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; Pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, Leiomyoma, endourology/stone, pre-eclampsia and pre-term labour; Pharmaceutical preparations for the treatment of prostatitis, nephritis, cystitis, vaginitis, renal disease; Pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders namely polycystic ovary syndrome; Pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; Pharmaceutical preparations for the treatment of alopecia and androgenic alopecia (male pattern baldness); Pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; Pharmaceutical preparations for the treatment of damaged skin and tissue namely bee stings, sunburn, rashes, sores, corns, calluses and acne; Pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; Pharmaceutical preparations for the treatment of malaria; Pharmaceutical preparations for the treatment of tuberculosis; Allergy medications; Vaccines namely prophylactic and therapeutic vaccines for humans; Pharmaceutical preparations for the treatment of neurological diseases and disorders namely Parkinson's Disease, Alzheimer's Disease, Huntington's Disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory-related pain, fibromyalgia, stroke, multiple sclerosis, insomnia; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders namely schizophrenia and psychoses; Pharmaceutical preparations for the treatment of muscular dystrophy
044
Class 044
Medical, Beauty & Agricultural Services
Cell and gene therapy services
Pharmaceutical preparations for use as anti-infectives; Pharmaceutical...
on 03 Oct 2013
COLUMBIA INSURANCE COMPANY
1580539 · 04 Jun 2012
008
Class 008
Hand Tool Products
Non-electric food slicers with interchangeable blades
Non-electric food slicers with interchangeable blades
on 20 Apr 2016
CONTINENTAL EMITEC VERWALTUNGS GMBH
1498191 · 01 Oct 2010
007
Class 007
Machinery Products
Combustion engines, apart from land vehicles as used in applications for not-road mobile machinery, locomotives, rail cars, ships, boats, electrical power generation units, pumps, compressors, chillers, drilling equipment and transportable refrigeration units, parts of combustion engines, including of combustion engines for land vehicles, namely, exhaust gas catalytic converters and catalytic converter carriers; electric and electronic monitoring, regulating and control apparatus and devices for use with exhaust gas catalytic converters, and parts for all of the aforesaid goods; combustion engines for land vehicles.
009
Class 009
Computer & Software Products & Electrical & Scientific Products
...
Class 012
Vehicles and Products for locomotion by land, air or water
Combustion engines, apart from land vehicles as used in applications f...
on 12 Oct 2011
DE PIES A CABEZA S.L.
1470375 · 22 Feb 2010
025
Class 025
Clothing Products
Children's clothing, namely coats, Bermuda shorts, bikinis, mufflers, shirts, waistcoats, tracksuits, jackets, swimsuits, skirts, bonnets, gloves, sweaters, mittens, culottes, trousers, shorts, rompers, dungarees, polo shirts, dresses and footwear.
Children's clothing, namely coats, Bermuda shorts, bikinis, mufflers, ...
Country
CA
Status
All
Registered
Pending
Abandoned
Other
Owners
Glaxo group limited (2)
Astrazeneca ab (1)
Bob ross inc. (1)
Canadian investment regulatory organization organisme canadien de réglementation des investissements (1)
Canadian residential inspection services limited (1)
Columbia insurance company (1)
Continental emitec verwaltungs gmbh (1)
Csl behring l.L.C. (1)
De pies a cabeza s.L. (1)
Emitec gesellschaft für emissionstechnologie mbh (1)
North carolina state university (1)
Novo nordisk a/s (1)
The hercules tire & rubber company (1)
Tricot princess inc.- princess knitting inc. (1)
Categories
Class 5 (5)
Class 41 (3)
Class 7 (2)
Class 9 (2)
Class 12 (2)
Class 25 (2)
Class 8 (1)
Class 31 (1)
Class 37 (1)
Class 44 (1)
Correspondents
Smart & biggar lp (3)
Borden ladner gervais llp (2)
Cassels brock & blackwell llp (1)
Gowling wlg (canada) llp (1)
Moffat & co. (1)
Norton rose fulbright canada llp/s.E.N.C.R.L.,s.R.L. (1)
Smart & biggar ip agency co. (1)
Torys llp (1)
Image Search
Drag and drop or upload to search any image